WILMINGTON, MASSACHUSETTS -- (MARKET WIRE) -- December 08, 2006 -- DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA) reported today that River's Edge Pharmaceuticals, LLC filed a motion late yesterday to lift the preliminary injunction entered in May by the United States District Court in New Jersey, prohibiting sales of River's Edge generic version of DUSA's Nicomide® product.
